Copyright Reports & Markets. All rights reserved.

Global Rectal Mesalazine Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Rectal Mesalazine by Type
    • 1.3.1 Overview: Global Rectal Mesalazine Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Rectal Mesalazine Consumption Value Market Share by Type in 2025
    • 1.3.3 Suppository
    • 1.3.4 Enema
  • 1.4 Global Rectal Mesalazine Market by Application
    • 1.4.1 Overview: Global Rectal Mesalazine Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Ulcerative Colitis
    • 1.4.3 Crohn's Disease
    • 1.4.4 Inflammatory Bowel Disease
  • 1.5 Global Rectal Mesalazine Market Size & Forecast
  • 1.6 Global Rectal Mesalazine Market Size and Forecast by Region
    • 1.6.1 Global Rectal Mesalazine Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Rectal Mesalazine Market Size by Region, (2021-2032)
    • 1.6.3 North America Rectal Mesalazine Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Rectal Mesalazine Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Rectal Mesalazine Market Size and Prospect (2021-2032)
    • 1.6.6 South America Rectal Mesalazine Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Rectal Mesalazine Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Ferring Global
    • 2.1.1 Ferring Global Details
    • 2.1.2 Ferring Global Major Business
    • 2.1.3 Ferring Global Rectal Mesalazine Product and Solutions
    • 2.1.4 Ferring Global Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Ferring Global Recent Developments and Future Plans
  • 2.2 AbbVie
    • 2.2.1 AbbVie Details
    • 2.2.2 AbbVie Major Business
    • 2.2.3 AbbVie Rectal Mesalazine Product and Solutions
    • 2.2.4 AbbVie Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 AbbVie Recent Developments and Future Plans
  • 2.3 Reid-Rowell
    • 2.3.1 Reid-Rowell Details
    • 2.3.2 Reid-Rowell Major Business
    • 2.3.3 Reid-Rowell Rectal Mesalazine Product and Solutions
    • 2.3.4 Reid-Rowell Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Reid-Rowell Recent Developments and Future Plans
  • 2.4 Dr. Falk Pharma UK
    • 2.4.1 Dr. Falk Pharma UK Details
    • 2.4.2 Dr. Falk Pharma UK Major Business
    • 2.4.3 Dr. Falk Pharma UK Rectal Mesalazine Product and Solutions
    • 2.4.4 Dr. Falk Pharma UK Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Dr. Falk Pharma UK Recent Developments and Future Plans
  • 2.5 Alaven Pharmaceutical
    • 2.5.1 Alaven Pharmaceutical Details
    • 2.5.2 Alaven Pharmaceutical Major Business
    • 2.5.3 Alaven Pharmaceutical Rectal Mesalazine Product and Solutions
    • 2.5.4 Alaven Pharmaceutical Rectal Mesalazine Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Alaven Pharmaceutical Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Rectal Mesalazine Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Rectal Mesalazine by Company Revenue
    • 3.2.2 Top 3 Rectal Mesalazine Players Market Share in 2025
    • 3.2.3 Top 6 Rectal Mesalazine Players Market Share in 2025
  • 3.3 Rectal Mesalazine Market: Overall Company Footprint Analysis
    • 3.3.1 Rectal Mesalazine Market: Region Footprint
    • 3.3.2 Rectal Mesalazine Market: Company Product Type Footprint
    • 3.3.3 Rectal Mesalazine Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Rectal Mesalazine Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Rectal Mesalazine Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Rectal Mesalazine Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Rectal Mesalazine Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Rectal Mesalazine Consumption Value by Type (2021-2032)
  • 6.2 North America Rectal Mesalazine Market Size by Application (2021-2032)
  • 6.3 North America Rectal Mesalazine Market Size by Country
    • 6.3.1 North America Rectal Mesalazine Consumption Value by Country (2021-2032)
    • 6.3.2 United States Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Rectal Mesalazine Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Rectal Mesalazine Consumption Value by Type (2021-2032)
  • 7.2 Europe Rectal Mesalazine Consumption Value by Application (2021-2032)
  • 7.3 Europe Rectal Mesalazine Market Size by Country
    • 7.3.1 Europe Rectal Mesalazine Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 7.3.3 France Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Rectal Mesalazine Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Rectal Mesalazine Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Rectal Mesalazine Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Rectal Mesalazine Market Size by Region
    • 8.3.1 Asia-Pacific Rectal Mesalazine Consumption Value by Region (2021-2032)
    • 8.3.2 China Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.5 India Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Rectal Mesalazine Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Rectal Mesalazine Consumption Value by Type (2021-2032)
  • 9.2 South America Rectal Mesalazine Consumption Value by Application (2021-2032)
  • 9.3 South America Rectal Mesalazine Market Size by Country
    • 9.3.1 South America Rectal Mesalazine Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Rectal Mesalazine Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Rectal Mesalazine Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Rectal Mesalazine Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Rectal Mesalazine Market Size by Country
    • 10.3.1 Middle East & Africa Rectal Mesalazine Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Rectal Mesalazine Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Rectal Mesalazine Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Rectal Mesalazine Market Drivers
  • 11.2 Rectal Mesalazine Market Restraints
  • 11.3 Rectal Mesalazine Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Rectal Mesalazine Industry Chain
  • 12.2 Rectal Mesalazine Upstream Analysis
  • 12.3 Rectal Mesalazine Midstream Analysis
  • 12.4 Rectal Mesalazine Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Rectal Mesalazine market size was valued at US$ 87.96 million in 2025 and is forecast to a readjusted size of US$ 112 million by 2032 with a CAGR of 3.5% during review period.
    Rectal mesalazine, also known as rectal 5-aminosalicylic acid (5-ASA) or rectal mesalamine, is a medication used to treat certain inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn"s disease. It is available in various forms, including suppositories and enemas, and is administered rectally.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Rectal Mesalazine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Rectal Mesalazine market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Rectal Mesalazine market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Rectal Mesalazine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Rectal Mesalazine market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Rectal Mesalazine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Rectal Mesalazine market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ferring Global, AbbVie, Reid-Rowell, Dr. Falk Pharma UK, Alaven Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Rectal Mesalazine market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Suppository
    Enema
    Market segment by Application
    Ulcerative Colitis
    Crohn's Disease
    Inflammatory Bowel Disease
    Market segment by players, this report covers
    Ferring Global
    AbbVie
    Reid-Rowell
    Dr. Falk Pharma UK
    Alaven Pharmaceutical
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Rectal Mesalazine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Rectal Mesalazine, with revenue, gross margin, and global market share of Rectal Mesalazine from 2021 to 2026.
    Chapter 3, the Rectal Mesalazine competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Rectal Mesalazine market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Rectal Mesalazine.
    Chapter 13, to describe Rectal Mesalazine research findings and conclusion.

    Buy now